Akebia Therapeutics
AKBA
#7450
Rank
HK$3.26 B
Marketcap
HK$12.29
Share price
-2.47%
Change (1 day)
-22.48%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: HK$3.26 Billion

As of December 2025 Akebia Therapeutics has a market cap of HK$3.26 Billion. This makes Akebia Therapeutics the world's 7450th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$3.26 B-1.23%
2024HK$3.30 B81.04%
2023HK$1.82 B119.99%
2022HK$0.82 B-73.1%
2021HK$3.08 B-1.73%
2020HK$3.13 B-47.61%
2019HK$5.98 B18.32%
2018HK$5.06 B-7.83%
2017HK$5.49 B77.51%
2016HK$3.09 B0.76%
2015HK$3.07 B66.95%
2014HK$1.83 B

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of Akebia Therapeutics was reported to be:

HK$3.26 Billion
by Nasdaq info icon info icon
HK$3.26 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
HK$1.314 T 40,207.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$1.955 T 59,855.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Johnson & Johnson
JNJ
HK$3.748 T 114,802.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
HK$9.30 B 185.18%๐Ÿ‡บ๐Ÿ‡ธ USA